Table of Content

1 INTRODUCTION (Page No. - 32)
    1.1 STUDY OBJECTIVES
    1.2 MARKET DEFINITION
           1.2.1 INCLUSIONS AND EXCLUSIONS
    1.3 MARKET SCOPE
           1.3.1 MARKETS COVERED
                    FIGURE 1 CLINICAL TRIAL SUPPLIES MARKET: GEOGRAPHIC SCOPE
           1.3.2 YEARS CONSIDERED
    1.4 CURRENCY
    1.5 LIMITATIONS
    1.6 STAKEHOLDERS
    1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY (Page No. - 38)
    2.1 RESEARCH APPROACH
          FIGURE 2 RESEARCH DESIGN
           2.1.1 SECONDARY DATA
           2.1.2 PRIMARY DATA
                    FIGURE 3 BREAKDOWN OF PRIMARIES: CLINICAL TRIAL SUPPLIES MARKET
    2.2 MARKET DATA ESTIMATION AND TRIANGULATION
          FIGURE 4 DATA TRIANGULATION METHODOLOGY
    2.3 MARKET ESTIMATION METHODOLOGY
          FIGURE 5 MARKET SIZE ESTIMATION APPROACH: COMPANY REVENUE ANALYSIS
          FIGURE 6 CLINICAL TRIAL SUPPLIES MARKET: FINAL MARKET SIZE (USD BILLION)
    2.4 GROWTH RATE ASSUMPTIONS/GROWTH FORECAST
          FIGURE 7 GROWTH RATE ASSUMPTION BASED ON MARKET DYNAMICS
          FIGURE 8 FINAL CAGR PROJECTIONS (2022−2027)
    2.5 INSIGHTS FROM PRIMARIES
          FIGURE 9 MARKET VALIDATION FROM PRIMARY EXPERTS
    2.6 RESEARCH ASSUMPTIONS
    2.7 RISK ASSESSMENT
          TABLE 1 RISK ASSESSMENT

3 EXECUTIVE SUMMARY (Page No. - 46)
    FIGURE 10 CLINICAL TRIAL SUPPLIES MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION)
    FIGURE 11 CLINICAL TRIAL SUPPLIES MARKET SHARE, BY SERVICE, 2021
    FIGURE 12 CLINICAL TRIAL SUPPLIES MARKET, BY PHASE, 2022 VS. 2027 (USD MILLION)
    FIGURE 13 CLINICAL TRIAL SUPPLIES MARKET SHARE, BY THERAPEUTIC AREA, 2021
    FIGURE 14 CLINICAL TRIAL SUPPLIES MARKET SHARE, BY END USER, 2021
    FIGURE 15 GEOGRAPHICAL SNAPSHOT OF CLINICAL TRIAL SUPPLIES MARKET

4 PREMIUM INSIGHTS (Page No. - 50)
    4.1 CLINICAL TRIAL SUPPLIES MARKET OVERVIEW
          FIGURE 16 INCREASING R&D EXPENDITURE OF PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES TO DRIVE MARKET
    4.2 NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET SHARE,  BY TYPE AND COUNTRY (2021)
          FIGURE 17 SMALL-MOLECULE DRUGS ACCOUNTED FOR LARGEST SHARE OF CLINICAL TRIAL SUPPLIES MARKET IN NORTH AMERICA
    4.3 CLINICAL TRIAL SUPPLIES MARKET: GEOGRAPHIC  GROWTH OPPORTUNITIES
          FIGURE 18 ASIA PACIFIC TO REGISTER HIGHEST GROWTH IN CLINICAL TRIAL SUPPLIES MARKET FROM 2022 TO 2027

5 MARKET OVERVIEW (Page No. - 53)
    5.1 INTRODUCTION
    5.2 MARKET DYNAMICS
          FIGURE 19 CLINICAL TRIAL SUPPLIES MARKET: DRIVERS, RESTRAINTS,  OPPORTUNITIES, AND CHALLENGES
    5.3 IMPACT ANALYSIS
           5.3.1 DRIVERS
                    5.3.1.1 Increasing R&D expenditure of pharmaceutical and biopharmaceutical companies
                    5.3.1.2 Increasing number of registered clinical trials
                                FIGURE 20 REGISTERED CLINICAL STUDIES, 2011–2022
                    5.3.1.3 Increasing decentralization of clinical trials
           5.3.2 RESTRAINTS
                    5.3.2.1 High cost of drug development
           5.3.3 OPPORTUNITIES
                    5.3.3.1 Emerging markets
           5.3.4 CHALLENGES
                    5.3.4.1 High cost of clinical trials
    5.4 RANGES/SCENARIOS
          FIGURE 21 SCENARIOS OF CLINICAL TRIAL SUPPLIES MARKET
    5.5 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
    5.6 VALUE CHAIN ANALYSIS
          FIGURE 22 VALUE CHAIN ANALYSIS OF CLINICAL TRIAL SUPPLIES MARKET
    5.7 ECOSYSTEM/MARKET MAP
    5.8 SUPPLY CHAIN
    5.9 PORTER’S FIVE FORCES ANALYSIS
          TABLE 2 PORTER’S FIVE FORCES ANALYSIS: CLINICAL TRIAL SUPPLIES MARKET
           5.9.1 THREAT OF NEW ENTRANTS
           5.9.2 THREAT OF SUBSTITUTES
           5.9.3 BARGAINING POWER OF SUPPLIERS
           5.9.4 BARGAINING POWER OF BUYERS
           5.9.5 DEGREE OF COMPETITION
    5.10 REGULATORY LANDSCAPE
           5.10.1 INTRODUCTION
    5.11 KEY CONFERENCES AND EVENTS IN 2022–2023
           TABLE 3 CLINICAL TRIAL SUPPLIES MARKET: DETAILED LIST OF CONFERENCES AND EVENTS
    5.12 TECHNOLOGY ANALYSIS
           5.12.1 INTERACTIVE RESPONSE TECHNOLOGY (IRT)
    5.13 PATENT ANALYSIS
            FIGURE 23 TOP PATENTS IN CLINICAL TRIAL SUPPLIES MARKET

6 CLINICAL TRIAL SUPPLIES MARKET, BY SERVICE (Page No. - 69)
    6.1 INTRODUCTION
          TABLE 4 CLINICAL TRIAL SUPPLIES MARKET, BY SERVICE, 2020–2027 (USD MILLION)
    6.2 LOGISTICS AND DISTRIBUTION
           6.2.1 EVOLVING TREATMENT PROTOCOLS AND DATA SECURITY CHALLENGES TO DRIVE DEMAND FOR LOGISTICS AND  DISTRIBUTION SERVICES
                    TABLE 5 CLINICAL TRIAL SUPPLIES MARKET FOR LOGISTICS AND DISTRIBUTION SERVICES,  BY REGION, 2020–2027 (USD MILLION)
                    TABLE 6 NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET FOR LOGISTICS AND DISTRIBUTION SERVICES, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 7 EUROPE: CLINICAL TRIAL SUPPLIES MARKET FOR LOGISTICS AND DISTRIBUTION SERVICES, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 8 ASIA PACIFIC: CLINICAL TRIAL SUPPLIES MARKET FOR LOGISTICS AND DISTRIBUTION SERVICES, BY COUNTRY, 2020–2027 (USD MILLION)
    6.3 STORAGE AND RETENTION
           6.3.1 GROWING DEMAND FOR DIRECT-TO-PATIENT AND DIRECT-TO-SITE SERVICES TO DRIVE GROWTH
                    TABLE 9 CLINICAL TRIAL SUPPLIES MARKET FOR STORAGE AND RETENTION SERVICES,  BY REGION, 2020–2027 (USD MILLION)
                    TABLE 10 NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET FOR STORAGE AND RETENTION SERVICES, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 11 EUROPE: CLINICAL TRIAL SUPPLIES MARKET FOR STORAGE AND RETENTION SERVICES,  BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 12 ASIA PACIFIC: CLINICAL TRIAL SUPPLIES MARKET FOR STORAGE AND RETENTION SERVICES, BY COUNTRY, 2020–2027 (USD MILLION)
    6.4 PACKAGING, LABELING, AND BLINDING
           6.4.1 RISING DEMAND FOR ADVANCED PACKAGING TO DRIVE MARKET
                    TABLE 13 CLINICAL TRIAL SUPPLIES MARKET FOR PACKAGING, LABELING, AND BLINDING SERVICES, BY REGION, 2020–2027 (USD MILLION)
                    TABLE 14 NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET FOR PACKAGING, LABELING,  AND BLINDING SERVICES, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 15 EUROPE: CLINICAL TRIAL SUPPLIES MARKET FOR PACKAGING, LABELING, AND BLINDING SERVICES, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 16 ASIA PACIFIC: CLINICAL TRIAL SUPPLIES MARKET FOR PACKAGING, LABELING, AND BLINDING SERVICES, BY COUNTRY, 2020–2027 (USD MILLION)
    6.5 MANUFACTURING
           6.5.1 GROWING FOCUS OF COMPANIES ON INCREASING THEIR MANUFACTURING CAPACITIES TO DRIVE MARKET
                    TABLE 17 CLINICAL TRIAL SUPPLIES MARKET FOR MANUFACTURING SERVICES, BY REGION,  2020–2027 (USD MILLION)
                    TABLE 18 NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET FOR MANUFACTURING SERVICES, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 19 EUROPE: CLINICAL TRIAL SUPPLIES MARKET FOR MANUFACTURING SERVICES,  BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 20 ASIA PACIFIC: CLINICAL TRIAL SUPPLIES MARKET FOR MANUFACTURING SERVICES,  BY COUNTRY, 2020–2027 (USD MILLION)
    6.6 COMPARATOR SOURCING
           6.6.1 INTENSE MARKET COMPETITION, REGULATORY PRESSURE, AND RISING NUMBER OF CLINICAL TRIALS IN EMERGING  COUNTRIES TO DRIVE GROWTH
                    TABLE 21 CLINICAL TRIAL SUPPLIES MARKET FOR COMPARATOR SOURCING SERVICES, BY REGION, 2020–2027 (USD MILLION)
                    TABLE 22 NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET FOR COMPARATOR SOURCING SERVICES, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 23 EUROPE: CLINICAL TRIAL SUPPLIES MARKET FOR COMPARATOR SOURCING SERVICES, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 24 ASIA PACIFIC: CLINICAL TRIAL SUPPLIES MARKET FOR COMPARATOR SOURCING SERVICES, BY COUNTRY, 2020–2027 (USD MILLION)
    6.7 OTHER SERVICES
          TABLE 25 CLINICAL TRIAL SUPPLIES MARKET FOR OTHER SERVICES, BY REGION,  2020–2027 (USD MILLION)
          TABLE 26 NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET FOR OTHER SERVICES,  BY COUNTRY, 2020–2027 (USD MILLION)
          TABLE 27 EUROPE: CLINICAL TRIAL SUPPLIES MARKET FOR OTHER SERVICES, BY COUNTRY,  2020–2027 (USD MILLION)
          TABLE 28 ASIA PACIFIC: CLINICAL TRIAL SUPPLIES MARKET FOR OTHER SERVICES, BY COUNTRY,  2020–2027 (USD MILLION)

7 CLINICAL TRIAL SUPPLIES MARKET, BY PHASE (Page No. - 83)
    7.1 INTRODUCTION
          TABLE 29 CLINICAL TRIAL SUPPLIES MARKET, BY PHASE, 2020–2027 (USD MILLION)
    7.2 PHASE III
           7.2.1 PHASE III TRIALS INVOLVE LARGE PATIENT POPULATION
                    TABLE 30 CLINICAL TRIAL SUPPLIES MARKET FOR PHASE III CLINICAL TRIALS, BY REGION,  2020–2027 (USD MILLION)
                    TABLE 31 NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET FOR PHASE III CLINICAL TRIALS,  BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 32 EUROPE: CLINICAL TRIAL SUPPLIES MARKET FOR PHASE III CLINICAL TRIALS,  BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 33 ASIA PACIFIC: CLINICAL TRIAL SUPPLIES MARKET FOR PHASE III CLINICAL TRIALS,  BY COUNTRY, 2020–2027 (USD MILLION)
    7.3 PHASE II
           7.3.1 PHASE II CLINICAL TRIALS HELP IN UNDERSTANDING EFFECTIVENESS OF DRUG AND FURTHER EVALUATING ITS SAFETY
                    TABLE 34 CLINICAL TRIAL SUPPLIES MARKET FOR PHASE II CLINICAL TRIALS, BY REGION,  2020–2027 (USD MILLION)
                    TABLE 35 NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET FOR PHASE II CLINICAL TRIALS,  BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 36 EUROPE: CLINICAL TRIAL SUPPLIES MARKET FOR PHASE II CLINICAL TRIALS,  BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 37 ASIA PACIFIC: CLINICAL TRIAL SUPPLIES MARKET FOR PHASE II CLINICAL TRIALS,  BY COUNTRY, 2020–2027 (USD MILLION)
    7.4 PHASE I
           7.4.1 QUALITY OF CLINICAL TRIAL SUPPLIES AND LOGISTICS PLAY VITAL ROLE IN PHASE I CLINICAL TRIALS
                    TABLE 38 CLINICAL TRIAL SUPPLIES MARKET FOR PHASE I CLINICAL TRIALS, BY REGION,  2020–2027 (USD MILLION)
                    TABLE 39 NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET FOR PHASE I CLINICAL TRIALS,  BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 40 EUROPE: CLINICAL TRIAL SUPPLIES MARKET FOR PHASE I CLINICAL TRIALS,  BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 41 ASIA PACIFIC: CLINICAL TRIAL SUPPLIES MARKET FOR PHASE I CLINICAL TRIALS,  BY COUNTRY, 2020–2027 (USD MILLION)
    7.5 PHASE IV
           7.5.1 PHASE IV STUDIES ALLOW RESEARCHERS TO OBSERVE LONG-TERM EFFECTS OF PARTICULAR DRUGS IN LARGER POOL OF PATIENTS
                    TABLE 42 CLINICAL TRIAL SUPPLIES MARKET FOR PHASE IV CLINICAL TRIALS, BY REGION,  2020–2027 (USD MILLION)
                    TABLE 43 NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET FOR PHASE IV CLINICAL TRIALS,  BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 44 EUROPE: CLINICAL TRIAL SUPPLIES MARKET FOR PHASE IV CLINICAL TRIALS,  BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 45 ASIA PACIFIC: CLINICAL TRIAL SUPPLIES MARKET FOR PHASE IV CLINICAL TRIALS,  BY COUNTRY, 2020–2027 (USD MILLION)
    7.6 BA/BE STUDIES
           7.6.1 PATENT EXPIRATION OF DRUGS TO INCREASE DEMAND FOR  BA/BE STUDIES
                    TABLE 46 CLINICAL TRIAL SUPPLIES MARKET FOR BA/BE STUDIES, BY REGION,  2020–2027 (USD MILLION)
                    TABLE 47 NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET FOR BA/BE STUDIES, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 48 EUROPE: CLINICAL TRIAL SUPPLIES MARKET FOR BA/BE STUDIES, BY COUNTRY,  2020–2027 (USD MILLION)
                    TABLE 49 ASIA PACIFIC: CLINICAL TRIAL SUPPLIES MARKET FOR BA/BE STUDIES, BY COUNTRY,  2020–2027 (USD MILLION)

8 CLINICAL TRIAL SUPPLIES MARKET, BY TYPE (Page No. - 95)
    8.1 INTRODUCTION
          TABLE 50 CLINICAL TRIAL SUPPLIES MARKET, BY TYPE, 2020–2027 (USD MILLION)
    8.2 SMALL-MOLECULE DRUGS
           8.2.1 LOW COST OF DEVELOPING SMALL-MOLECULE DRUGS TO DRIVE MARKET
                    TABLE 51 CLINICAL TRIAL SUPPLIES MARKET FOR SMALL-MOLECULE DRUGS, BY REGION,  2020–2027 (USD MILLION)
                    TABLE 52 NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET FOR SMALL-MOLECULE DRUGS,  BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 53 EUROPE: CLINICAL TRIAL SUPPLIES MARKET FOR SMALL-MOLECULE DRUGS,  BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 54 ASIA PACIFIC: CLINICAL TRIAL SUPPLIES MARKET FOR SMALL-MOLECULE DRUGS,  BY COUNTRY, 2020–2027 (USD MILLION)
    8.3 BIOLOGIC DRUGS
           8.3.1 BIOLOGIC DRUGS HAVE RELATIVELY LOW RATE OF ATTRITION COMPARED TO SMALL-MOLECULE DRUGS
                    TABLE 55 CLINICAL TRIAL SUPPLIES MARKET FOR BIOLOGIC DRUGS, BY REGION,  2020–2027 (USD MILLION)
                    TABLE 56 NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET FOR BIOLOGIC DRUGS,  BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 57 EUROPE: CLINICAL TRIAL SUPPLIES MARKET FOR BIOLOGIC DRUGS, BY COUNTRY,  2020–2027 (USD MILLION)
                    TABLE 58 ASIA PACIFIC: CLINICAL TRIAL SUPPLIES MARKET FOR BIOLOGIC DRUGS, BY COUNTRY,  2020–2027 (USD MILLION)
    8.4 MEDICAL DEVICES
           8.4.1 INCREASING NUMBER OF TRIALS FOR MEDICAL DEVICES TO DRIVE  MARKET
                    TABLE 59 CLINICAL TRIAL SUPPLIES MARKET FOR MEDICAL DEVICES, BY REGION,  2020–2027 (USD MILLION)
                    TABLE 60 NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET FOR MEDICAL DEVICES,  BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 61 EUROPE: CLINICAL TRIAL SUPPLIES MARKET FOR MEDICAL DEVICES, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 62 ASIA PACIFIC: CLINICAL TRIAL SUPPLIES MARKET FOR MEDICAL DEVICES, BY COUNTRY, 2020–2027 (USD MILLION)

9 CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC AREA (Page No. - 103)
    9.1 INTRODUCTION
          TABLE 63 CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION)
    9.2 ONCOLOGY
           9.2.1 GROWING STUDIES ON CANCER THERAPEUTICS TO DRIVE  MARKET
                    TABLE 64 CLINICAL TRIAL SUPPLIES MARKET FOR ONCOLOGY, BY REGION,  2020–2027 (USD MILLION)
                    TABLE 65 NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET FOR ONCOLOGY, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 66 EUROPE: CLINICAL TRIAL SUPPLIES MARKET FOR ONCOLOGY, BY COUNTRY,  2020–2027 (USD MILLION)
                    TABLE 67 ASIA PACIFIC: CLINICAL TRIAL SUPPLIES MARKET FOR ONCOLOGY, BY COUNTRY,  2020–2027 (USD MILLION)
    9.3 CNS AND MENTAL DISORDERS
           9.3.1 INCREASING CASES OF MENTAL DISORDERS TO DRIVE  MARKET
                    TABLE 68 CLINICAL TRIAL SUPPLIES MARKET FOR CNS AND MENTAL DISORDERS, BY REGION,  2020–2027 (USD MILLION)
                    TABLE 69 NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET FOR CNS AND MENTAL DISORDERS, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 70 EUROPE: CLINICAL TRIAL SUPPLIES MARKET FOR CNS AND MENTAL DISORDERS,  BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 71 ASIA PACIFIC: CLINICAL TRIAL SUPPLIES MARKET FOR CNS AND MENTAL DISORDERS,  BY COUNTRY, 2020–2027 (USD MILLION)
    9.4 CARDIOVASCULAR DISEASES
           9.4.1 GROWING INVESTMENTS BY PHARMACEUTICAL COMPANIES FOR CVD RESEARCH TO DRIVE GROWTH
                    TABLE 72 CLINICAL TRIAL SUPPLIES MARKET FOR CARDIOVASCULAR DISEASES, BY REGION, 2020–2027 (USD MILLION)
                    TABLE 73 NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 74 EUROPE: CLINICAL TRIAL SUPPLIES MARKET FOR CARDIOVASCULAR DISEASES,  BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 75 ASIA PACIFIC: CLINICAL TRIAL SUPPLIES MARKET FOR CARDIOVASCULAR DISEASES,  BY COUNTRY, 2020–2027 (USD MILLION)
    9.5 DIGESTIVE DISORDERS
           9.5.1 INCREASING R&D FOR DEVELOPMENT OF EFFECTIVE DRUGS TO DRIVE MARKET
                    TABLE 76 CLINICAL TRIAL SUPPLIES MARKET FOR DIGESTIVE DISORDERS, BY REGION,  2020–2027 (USD MILLION)
                    TABLE 77 NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET FOR DIGESTIVE DISORDERS,  BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 78 EUROPE: CLINICAL TRIAL SUPPLIES MARKET FOR DIGESTIVE DISORDERS, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 79 ASIA PACIFIC: CLINICAL TRIAL SUPPLIES MARKET FOR DIGESTIVE DISORDERS,  BY COUNTRY, 2020–2027 (USD MILLION)
    9.6 INFECTIOUS DISEASES
           9.6.1 EMERGENCE OF NEW INFECTIONS SUCH AS EBOLA, ZIKA,  AND COVID-19 ACCELERATED EFFORTS TO DEVELOP  NEW DRUGS
                    TABLE 80 CLINICAL TRIAL SUPPLIES MARKET FOR INFECTIOUS DISEASES, BY REGION,  2020–2027 (USD MILLION)
                    TABLE 81 NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET FOR INFECTIOUS DISEASES,  BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 82 EUROPE: CLINICAL TRIAL SUPPLIES MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 83 ASIA PACIFIC: CLINICAL TRIAL SUPPLIES MARKET FOR INFECTIOUS DISEASES,  BY COUNTRY, 2020–2027 (USD MILLION)
    9.7 METABOLIC DISORDERS
           9.7.1 INCREASING PREVALENCE OF DIABETES AND OTHER METABOLIC DISORDERS TO DRIVE GROWTH
                    TABLE 84 CLINICAL TRIAL SUPPLIES MARKET FOR METABOLIC DISORDERS, BY REGION,  2020–2027 (USD MILLION)
                    TABLE 85 NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET FOR METABOLIC DISORDERS,  BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 86 EUROPE: CLINICAL TRIAL SUPPLIES MARKET FOR METABOLIC DISORDERS, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 87 ASIA PACIFIC: CLINICAL TRIAL SUPPLIES MARKET FOR METABOLIC DISORDERS,  BY COUNTRY, 2020–2027 (USD MILLION)
    9.8 BLOOD DISORDERS
           9.8.1 GROWTH IN NUMBER OF HEMOPHILIA PATIENTS TO BOOST PRODUCTION OF MACROMOLECULES AND RECOMBINANT FACTORS
                    TABLE 88 CLINICAL TRIAL SUPPLIES MARKET FOR BLOOD DISORDERS, BY REGION,  2020–2027 (USD MILLION)
                    TABLE 89 NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET FOR BLOOD DISORDERS,  BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 90 EUROPE: CLINICAL TRIAL SUPPLIES MARKET FOR BLOOD DISORDERS, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 91 ASIA PACIFIC: CLINICAL TRIAL SUPPLIES MARKET FOR BLOOD DISORDERS, BY COUNTRY, 2020–2027 (USD MILLION)
    9.9 IMMUNOLOGY
           9.9.1 CONTINUOUS GROWTH IN CLINICAL STUDIES FOR IMMUNE  SYSTEM DISEASES TO FUEL NEED FOR PROCURING  CLINICAL TRIAL SUPPLIES
                    TABLE 92 CLINICAL TRIAL SUPPLIES MARKET FOR IMMUNOLOGY, BY REGION,  2020–2027 (USD MILLION)
                    TABLE 93 NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET FOR IMMUNOLOGY, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 94 EUROPE: CLINICAL TRIAL SUPPLIES MARKET FOR IMMUNOLOGY, BY COUNTRY,  2020–2027 (USD MILLION)
                    TABLE 95 ASIA PACIFIC: CLINICAL TRIAL SUPPLIES MARKET FOR IMMUNOLOGY, BY COUNTRY,  2020–2027 (USD MILLION)
    9.10 OTHER THERAPEUTIC AREAS
           TABLE 96 CLINICAL TRIAL SUPPLIES MARKET FOR OTHER THERAPEUTIC AREAS, BY REGION,  2020–2027 (USD MILLION)
           TABLE 97 NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET FOR OTHER THERAPEUTIC AREAS, BY COUNTRY, 2020–2027 (USD MILLION)
           TABLE 98 EUROPE: CLINICAL TRIAL SUPPLIES MARKET FOR OTHER THERAPEUTIC AREAS,  BY COUNTRY, 2020–2027 (USD MILLION)
           TABLE 99 ASIA PACIFIC: CLINICAL TRIAL SUPPLIES MARKET FOR OTHER THERAPEUTIC AREAS,  BY COUNTRY, 2020–2027 (USD MILLION)

10 CLINICAL TRIAL SUPPLIES MARKET, BY END USER (Page No. - 123)
     10.1 INTRODUCTION
             TABLE 100 CLINICAL TRIAL SUPPLIES MARKET, BY END USER, 2020–2027 (USD MILLION)
     10.2 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
             10.2.1 INCREASING R&D INVESTMENTS TO BOOST OUTSOURCING  OF CLINICAL TRIAL SUPPLIES BY PHARMACEUTICAL AND  BIOTECHNOLOGY COMPANIES
                        TABLE 101 CLINICAL TRIAL SUPPLIES MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2020–2027 (USD MILLION)
                        TABLE 102 NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION)
                        TABLE 103 EUROPE: CLINICAL TRIAL SUPPLIES MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION)
                        TABLE 104 ASIA PACIFIC: CLINICAL TRIAL SUPPLIES MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION)
     10.3 CONTRACT RESEARCH ORGANIZATIONS
             10.3.1 INCREASING OUTSOURCING OF CLINICAL TRIALS TO DRIVE ADOPTION OF CLINICAL TRIAL SUPPLIES AMONG CROS
                        TABLE 105 CLINICAL TRIAL SUPPLIES MARKET FOR CONTRACT RESEARCH ORGANIZATIONS,  BY REGION, 2020–2027 (USD MILLION)
                        TABLE 106 NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
                        TABLE 107 EUROPE: CLINICAL TRIAL SUPPLIES MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
                        TABLE 108 ASIA PACIFIC: CLINICAL TRIAL SUPPLIES MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
     10.4 MEDICAL DEVICE COMPANIES
             10.4.1 INCREASING NUMBER OF TRIALS OF MEDICAL DEVICES TO DRIVE  MARKET
                        TABLE 109 CLINICAL TRIAL SUPPLIES MARKET FOR MEDICAL DEVICE COMPANIES, BY REGION, 2020–2027 (USD MILLION)
                        TABLE 110 NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET FOR MEDICAL DEVICE COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION)
                        TABLE 111 EUROPE: CLINICAL TRIAL SUPPLIES MARKET FOR MEDICAL DEVICE COMPANIES,  BY COUNTRY, 2020–2027 (USD MILLION)
                        TABLE 112 ASIA PACIFIC: CLINICAL TRIAL SUPPLIES MARKET FOR MEDICAL DEVICE COMPANIES,  BY COUNTRY, 2020–2027 (USD MILLION)

11 CLINICAL TRIAL SUPPLIES MARKET, BY REGION (Page No. - 131)
     11.1 INTRODUCTION
             TABLE 113 CLINICAL TRIAL SUPPLIES MARKET, BY REGION, 2020–2027 (USD MILLION)
     11.2 NORTH AMERICA
             TABLE 114 NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET, BY COUNTRY,  2020–2027 (USD MILLION)
             TABLE 115 NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET, BY SERVICE,  2020–2027 (USD MILLION)
             TABLE 116 NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET, BY PHASE,  2020–2027 (USD MILLION)
             TABLE 117 NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET, BY TYPE,  2020–2027 (USD MILLION)
             TABLE 118 NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC AREA,  2020–2027 (USD MILLION)
             TABLE 119 NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET, BY END USER,  2020–2027 (USD MILLION)
             11.2.1 US
                        11.2.1.1 Increasing R&D investments to drive market
                                      TABLE 120 US: CLINICAL TRIAL SUPPLIES MARKET, BY SERVICE, 2020–2027 (USD MILLION)
                                      TABLE 121 US: CLINICAL TRIAL SUPPLIES MARKET, BY PHASE, 2020–2027 (USD MILLION)
                                      TABLE 122 US: CLINICAL TRIAL SUPPLIES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 123 US: CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC AREA,  2020–2027 (USD MILLION)
                                      TABLE 124 US: CLINICAL TRIAL SUPPLIES MARKET, BY END USER, 2020–2027 (USD MILLION)
             11.2.2 CANADA
                        11.2.2.1 Growing preference of pharmaceutical companies to conduct trials in Canada to favor market growth
                                      TABLE 125 CANADA: CLINICAL TRIAL SUPPLIES MARKET, BY SERVICE, 2020–2027 (USD MILLION)
                                      TABLE 126 CANADA: CLINICAL TRIAL SUPPLIES MARKET, BY PHASE, 2020–2027 (USD MILLION)
                                      TABLE 127 CANADA: CLINICAL TRIAL SUPPLIES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 128 CANADA: CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC AREA,  2020–2027 (USD MILLION)
                                      TABLE 129 CANADA: CLINICAL TRIAL SUPPLIES MARKET, BY END USER, 2020–2027 (USD MILLION)
     11.3 EUROPE
             TABLE 130 EUROPE: CLINICAL TRIAL SUPPLIES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
             TABLE 131 EUROPE: CLINICAL TRIAL SUPPLIES MARKET, BY SERVICE, 2020–2027 (USD MILLION)
             TABLE 132 EUROPE: CLINICAL TRIAL SUPPLIES MARKET, BY PHASE, 2020–2027 (USD MILLION)
             TABLE 133 EUROPE: CLINICAL TRIAL SUPPLIES MARKET, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 134 EUROPE: CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC AREA,  2020–2027 (USD MILLION)
             TABLE 135 EUROPE: CLINICAL TRIAL SUPPLIES MARKET, BY END USER, 2020–2027 (USD MILLION)
             11.3.1 GERMANY
                        11.3.1.1 Growing number of sponsored trials to boost demand for clinical trial supplies
                                      TABLE 136 GERMANY: CLINICAL TRIAL SUPPLIES MARKET, BY SERVICE, 2020–2027 (USD MILLION)
                                      TABLE 137 GERMANY: CLINICAL TRIAL SUPPLIES MARKET, BY PHASE, 2020–2027 (USD MILLION)
                                      TABLE 138 GERMANY: CLINICAL TRIAL SUPPLIES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 139 GERMANY: CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC AREA,  2020–2027 (USD MILLION)
                                      TABLE 140 GERMANY: CLINICAL TRIAL SUPPLIES MARKET, BY END USER,  2020–2027 (USD MILLION)
             11.3.2 UK
                        11.3.2.1 Government policies leading to costlier R&D and supply chain restrictions post Brexit to limit market growth
                                      TABLE 141 UK: CLINICAL TRIAL SUPPLIES MARKET, BY SERVICE, 2020–2027 (USD MILLION)
                                      TABLE 142 UK: CLINICAL TRIAL SUPPLIES MARKET, BY PHASE, 2020–2027 (USD MILLION)
                                      TABLE 143 UK: CLINICAL TRIAL SUPPLIES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 144 UK: CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC AREA,  2020–2027 (USD MILLION)
                                      TABLE 145 UK: CLINICAL TRIAL SUPPLIES MARKET, BY END USER, 2020–2027 (USD MILLION)
             11.3.3 FRANCE
                        11.3.3.1 Presence of leading pharmaceutical companies to support market growth
                                      TABLE 146 FRANCE: CLINICAL TRIAL SUPPLIES MARKET, BY SERVICE, 2020–2027 (USD MILLION)
                                      TABLE 147 FRANCE: CLINICAL TRIAL SUPPLIES MARKET, BY PHASE, 2020–2027 (USD MILLION)
                                      TABLE 148 FRANCE: CLINICAL TRIAL SUPPLIES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 149 FRANCE: CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC AREA,  2020–2027 (USD MILLION)
                                      TABLE 150 FRANCE: CLINICAL TRIAL SUPPLIES MARKET, BY END USER, 2020–2027 (USD MILLION)
             11.3.4 ITALY
                        11.3.4.1 Increasing number of drug approvals to drive market for clinical trial supplies
                                      TABLE 151 ITALY: CLINICAL TRIAL SUPPLIES MARKET, BY SERVICE, 2020–2027 (USD MILLION)
                                      TABLE 152 ITALY: CLINICAL TRIAL SUPPLIES MARKET, BY PHASE, 2020–2027 (USD MILLION)
                                      TABLE 153 ITALY: CLINICAL TRIAL SUPPLIES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 154 ITALY: CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC AREA,  2020–2027 (USD MILLION)
                                      TABLE 155 ITALY: CLINICAL TRIAL SUPPLIES MARKET, BY END USER, 2020–2027 (USD MILLION)
             11.3.5 SPAIN
                        11.3.5.1 Increasing biologics production to support market growth
                                      TABLE 156 SPAIN: CLINICAL TRIAL SUPPLIES MARKET, BY SERVICE, 2020–2027 (USD MILLION)
                                      TABLE 157 SPAIN: CLINICAL TRIAL SUPPLIES MARKET, BY PHASE, 2020–2027 (USD MILLION)
                                      TABLE 158 SPAIN: CLINICAL TRIAL SUPPLIES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 159 SPAIN: CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC AREA,  2020–2027 (USD MILLION)
                                      TABLE 160 SPAIN: CLINICAL TRIAL SUPPLIES MARKET, BY END USER, 2020–2027 (USD MILLION)
             11.3.6 SWITZERLAND
                        11.3.6.1 Growing R&D efforts to provide growth opportunities for clinical trial supplies market
                                      TABLE 161 SWITZERLAND: CLINICAL TRIAL SUPPLIES MARKET, BY SERVICE,  2020–2027 (USD MILLION)
                                      TABLE 162 SWITZERLAND: CLINICAL TRIAL SUPPLIES MARKET, BY PHASE,  2020–2027 (USD MILLION)
                                      TABLE 163 SWITZERLAND: CLINICAL TRIAL SUPPLIES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 164 SWITZERLAND: CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC AREA,  2020–2027 (USD MILLION)
                                      TABLE 165 SWITZERLAND: CLINICAL TRIAL SUPPLIES MARKET, BY END USER,  2020–2027 (USD MILLION)
             11.3.7 REST OF EUROPE
                        TABLE 166 REST OF EUROPE: CLINICAL TRIAL SUPPLIES MARKET, BY SERVICE,  2020–2027 (USD MILLION)
                        TABLE 167 REST OF EUROPE: CLINICAL TRIAL SUPPLIES MARKET, BY PHASE,  2020–2027 (USD MILLION)
                        TABLE 168 REST OF EUROPE: CLINICAL TRIAL SUPPLIES MARKET, BY TYPE,  2020–2027 (USD MILLION)
                        TABLE 169 REST OF EUROPE: CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC AREA,  2020–2027 (USD MILLION)
                        TABLE 170 REST OF EUROPE: CLINICAL TRIAL SUPPLIES MARKET, BY END USER,  2020–2027 (USD MILLION)
     11.4 ASIA PACIFIC
             TABLE 171 ASIA PACIFIC: CLINICAL TRIAL SUPPLIES MARKET, BY COUNTRY,  2020–2027 (USD MILLION)
             TABLE 172 ASIA PACIFIC: CLINICAL TRIAL SUPPLIES MARKET, BY SERVICE,  2020–2027 (USD MILLION)
             TABLE 173 ASIA PACIFIC: CLINICAL TRIAL SUPPLIES MARKET, BY PHASE, 2020–2027 (USD MILLION)
             TABLE 174 ASIA PACIFIC: CLINICAL TRIAL SUPPLIES MARKET, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 175 ASIA PACIFIC: CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC AREA,  2020–2027 (USD MILLION)
             TABLE 176 ASIA PACIFIC: CLINICAL TRIAL SUPPLIES MARKET, BY END USER,  2020–2027 (USD MILLION)
             11.4.1 CHINA
                        11.4.1.1 Favorable government regulations to boost market growth
                                      TABLE 177 CHINA: CLINICAL TRIAL SUPPLIES MARKET, BY SERVICE, 2020–2027 (USD MILLION)
                                      TABLE 178 CHINA: CLINICAL TRIAL SUPPLIES MARKET, BY PHASE, 2020–2027 (USD MILLION)
                                      TABLE 179 CHINA: CLINICAL TRIAL SUPPLIES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 180 CHINA: CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC AREA,  2020–2027 (USD MILLION)
                                      TABLE 181 CHINA: CLINICAL TRIAL SUPPLIES MARKET, BY END USER, 2020–2027 (USD MILLION)
             11.4.2 JAPAN
                        11.4.2.1 Government initiatives for drug innovation to support market growth
                                      TABLE 182 JAPAN: CLINICAL TRIAL SUPPLIES MARKET, BY SERVICE, 2020–2027 (USD MILLION)
                                      TABLE 183 JAPAN: CLINICAL TRIAL SUPPLIES MARKET, BY PHASE, 2020–2027 (USD MILLION)
                                      TABLE 184 JAPAN: CLINICAL TRIAL SUPPLIES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 185 JAPAN: CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC AREA,  2020–2027 (USD MILLION)
                                      TABLE 186 JAPAN: CLINICAL TRIAL SUPPLIES MARKET, BY END USER, 2020–2027 (USD MILLION)
             11.4.3 INDIA
                        11.4.3.1 Low manufacturing costs and skilled workforce—factors attracting outsourcing and investment to India
                                      TABLE 187 INDIA: CLINICAL TRIAL SUPPLIES MARKET, BY SERVICE, 2020–2027 (USD MILLION)
                                      TABLE 188 INDIA: CLINICAL TRIAL SUPPLIES MARKET, BY PHASE, 2020–2027 (USD MILLION)
                                      TABLE 189 INDIA: CLINICAL TRIAL SUPPLIES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 190 INDIA: CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC AREA,  2020–2027 (USD MILLION)
                                      TABLE 191 INDIA: CLINICAL TRIAL SUPPLIES MARKET, BY END USER, 2020–2027 (USD MILLION)
             11.4.4 AUSTRALIA
                        11.4.4.1 Favorable location for drug discovery due to presence of many research institutes
                                      TABLE 192 AUSTRALIA: CLINICAL TRIAL SUPPLIES MARKET, BY SERVICE, 2020–2027 (USD MILLION)
                                      TABLE 193 AUSTRALIA: CLINICAL TRIAL SUPPLIES MARKET, BY PHASE, 2020–2027 (USD MILLION)
                                      TABLE 194 AUSTRALIA: CLINICAL TRIAL SUPPLIES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 195 AUSTRALIA: CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC AREA,  2020–2027 (USD MILLION)
                                      TABLE 196 AUSTRALIA: CLINICAL TRIAL SUPPLIES MARKET, BY END USER,  2020–2027 (USD MILLION)
             11.4.5 SOUTH KOREA
                        11.4.5.1 Seoul among world’s largest clinical research centers
                                      TABLE 197 SOUTH KOREA: CLINICAL TRIAL SUPPLIES MARKET, BY SERVICE,  2020–2027 (USD MILLION)
                                      TABLE 198 SOUTH KOREA: CLINICAL TRIAL SUPPLIES MARKET, BY PHASE,  2020–2027 (USD MILLION)
                                      TABLE 199 SOUTH KOREA: CLINICAL TRIAL SUPPLIES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 200 SOUTH KOREA: CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC AREA,  2020–2027 (USD MILLION)
                                      TABLE 201 SOUTH KOREA: CLINICAL TRIAL SUPPLIES MARKET, BY END USER,  2020–2027 (USD MILLION)
             11.4.6 SINGAPORE
                        11.4.6.1 Presence of world-class infrastructure to drive market
                                      TABLE 202 SINGAPORE: CLINICAL TRIAL SUPPLIES MARKET, BY SERVICE,  2020–2027 (USD MILLION)
                                      TABLE 203 SINGAPORE: CLINICAL TRIAL SUPPLIES MARKET, BY PHASE, 2020–2027 (USD MILLION)
                                      TABLE 204 SINGAPORE: CLINICAL TRIAL SUPPLIES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 205 SINGAPORE: CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC AREA,  2020–2027 (USD MILLION)
                                      TABLE 206 SINGAPORE: CLINICAL TRIAL SUPPLIES MARKET, BY END USER,  2020–2027 (USD MILLION)
             11.4.7 REST OF ASIA PACIFIC
                        TABLE 207 REST OF ASIA PACIFIC: CLINICAL TRIAL SUPPLIES MARKET, BY SERVICE,  2020–2027 (USD MILLION)
                        TABLE 208 REST OF ASIA PACIFIC: CLINICAL TRIAL SUPPLIES MARKET, BY PHASE,  2020–2027 (USD MILLION)
                        TABLE 209 REST OF ASIA PACIFIC: CLINICAL TRIAL SUPPLIES MARKET, BY TYPE,  2020–2027 (USD MILLION)
                        TABLE 210 REST OF ASIA PACIFIC: CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC AREA,  2020–2027 (USD MILLION)
                        TABLE 211 REST OF ASIA PACIFIC: CLINICAL TRIAL SUPPLIES MARKET, BY END USER,  2020–2027 (USD MILLION)
     11.5 REST OF THE WORLD
             TABLE 212 REST OF THE WORLD: CLINICAL TRIAL SUPPLIES MARKET, BY REGION,  2020–2027 (USD MILLION)
             TABLE 213 REST OF THE WORLD: CLINICAL TRIAL SUPPLIES MARKET, BY SERVICE,  2020–2027 (USD MILLION)
             TABLE 214 REST OF THE WORLD: CLINICAL TRIAL SUPPLIES MARKET, BY PHASE,  2020–2027 (USD MILLION)
             TABLE 215 REST OF THE WORLD: CLINICAL TRIAL SUPPLIES MARKET, BY TYPE,  2020–2027 (USD MILLION)
             TABLE 216 REST OF THE WORLD: CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC AREA,  2020–2027 (USD MILLION)
             TABLE 217 REST OF THE WORLD: CLINICAL TRIAL SUPPLIES MARKET, BY END USER,  2020–2027 (USD MILLION)
             11.5.1 LATIN AMERICA
                        11.5.1.1 Growing R&D expenditure in pharmaceutical and biopharmaceutical sector to drive market
                                      TABLE 218 LATIN AMERICA: CLINICAL TRIAL SUPPLIES MARKET, BY SERVICE,  2020–2027 (USD MILLION)
                                      TABLE 219 LATIN AMERICA: CLINICAL TRIAL SUPPLIES MARKET, BY PHASE,  2020–2027 (USD MILLION)
                                      TABLE 220 LATIN AMERICA: CLINICAL TRIAL SUPPLIES MARKET, BY TYPE,  2020–2027 (USD MILLION)
                                      TABLE 221 LATIN AMERICA: CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC AREA,  2020–2027 (USD MILLION)
                                      TABLE 222 LATIN AMERICA: CLINICAL TRIAL SUPPLIES MARKET, BY END USER,  2020–2027 (USD MILLION)
             11.5.2 MIDDLE EAST AND AFRICA
                        11.5.2.1 Growing presence of pharmaceutical companies to drive market
                                      TABLE 223 MIDDLE EAST AND AFRICA: CLINICAL TRIAL SUPPLIES MARKET, BY SERVICE,  2020–2027 (USD MILLION)
                                      TABLE 224 MIDDLE EAST AND AFRICA: CLINICAL TRIAL SUPPLIES MARKET, BY PHASE,  2020–2027 (USD MILLION)
                                      TABLE 225 MIDDLE EAST AND AFRICA: CLINICAL TRIAL SUPPLIES MARKET, BY TYPE,  2020–2027 (USD MILLION)
                                      TABLE 226 MIDDLE EAST AND AFRICA: CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION)
                                      TABLE 227 MIDDLE EAST AND AFRICA: CLINICAL TRIAL SUPPLIES MARKET, BY END USER,  2020–2027 (USD MILLION)

12 COMPETITIVE LANDSCAPE (Page No. - 201)
     12.1 OVERVIEW
     12.2 RIGHT-TO-WIN APPROACHES ADOPTED BY KEY PLAYERS
             FIGURE 27 CLINICAL TRIAL SUPPLIES MARKET: STRATEGIES ADOPTED BY KEY PLAYERS
     12.3 REVENUE SHARE ANALYSIS OF KEY MARKET PLAYERS
             FIGURE 28 KEY PLAYERS IN CLINICAL TRIAL SUPPLIES MARKET
     12.4 MARKET SHARE ANALYSIS
             FIGURE 29 CLINICAL TRIAL SUPPLIES MARKET SHARE, BY KEY PLAYER, 2021
     12.5 COMPANY EVALUATION QUADRANT
             12.5.1 STARS
             12.5.2 EMERGING LEADERS
             12.5.3 PERVASIVE PLAYERS
             12.5.4 PARTICIPANTS
                        FIGURE 30 CLINICAL TRIAL SUPPLIES MARKET: COMPANY EVALUATION QUADRANT, 2021
     12.6 COMPANY EVALUATION QUADRANT FOR STARTUPS/SMES
             12.6.1 PROGRESSIVE COMPANIES
             12.6.2 STARTING BLOCKS
             12.6.3 RESPONSIVE COMPANIES
             12.6.4 DYNAMIC COMPANIES
                        FIGURE 31 CLINICAL TRIAL SUPPLIES MARKET: COMPANY EVALUATION QUADRANT FOR STARTUPS/SMES, 2021
     12.7 COMPETITIVE BENCHMARKING
             TABLE 228 CLINICAL TRIAL SUPPLIES MARKET: DETAILED LIST OF KEY STARTUPS/SMES
             12.7.1 FOOTPRINT ANALYSIS OF COMPANIES
                        TABLE 229 SERVICE FOOTPRINT OF COMPANIES
                        TABLE 230 REGIONAL FOOTPRINT OF COMPANIES
     12.8 COMPETITIVE SCENARIO
             TABLE 231 SERVICE LAUNCHES
             TABLE 232 DEALS
             TABLE 233 OTHER DEVELOPMENTS

13 COMPANY PROFILES (Page No. - 216)
     13.1 MAJOR PLAYERS
(Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)*
             13.1.1 THERMO FISHER SCIENTIFIC
                        TABLE 234 THERMO FISHER SCIENTIFIC: BUSINESS OVERVIEW
                        FIGURE 32 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2021)
             13.1.2 CATALENT, INC.
                        TABLE 235 CATALENT, INC.: BUSINESS OVERVIEW
                        FIGURE 33 CATALENT, INC.: COMPANY SNAPSHOT (2021)
             13.1.3 MARKEN (SUBSIDIARY OF UPS)
                        TABLE 236 UPS: BUSINESS OVERVIEW
                        FIGURE 34 UPS: COMPANY SNAPSHOT (2021)
             13.1.4 EUROFINS SCIENTIFIC
                        TABLE 237 EUROFINS SCIENTIFIC: BUSINESS OVERVIEW
                        FIGURE 35 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2021)
             13.1.5 PRA HEALTH SCIENCES (SUBSIDIARY OF ICON PLC)
                        TABLE 238 ICON PLC: BUSINESS OVERVIEW
                        FIGURE 36 ICON PLC: COMPANY SNAPSHOT (2021)
             13.1.6 PAREXEL INTERNATIONAL CORPORATION
                        TABLE 239 PAREXEL INTERNATIONAL CORPORATION: BUSINESS OVERVIEW
             13.1.7 BIOCAIR
                        TABLE 240 BIOCAIR: BUSINESS OVERVIEW
             13.1.8 ALMAC GROUP
                        TABLE 241 ALMAC GROUP: BUSINESS OVERVIEW
             13.1.9 PIRAMAL PHARMA SOLUTIONS
                        TABLE 242 PIRAMAL PHARMA SOLUTIONS: BUSINESS OVERVIEW
                        FIGURE 37 PIRAMAL PHARMA SOLUTIONS: COMPANY SNAPSHOT (2022)
             13.1.10 INFOSYS
                        TABLE 243 INFOSYS: BUSINESS OVERVIEW
                        FIGURE 38 INFOSYS: COMPANY SNAPSHOT (2022)
             13.1.11 PCI PHARMA SERVICES
                        TABLE 244 PCI PHARMA SERVICES: BUSINESS OVERVIEW
             13.1.12 LIVEO RESEARCH
                        TABLE 245 LIVEO RESEARCH: BUSINESS OVERVIEW
             13.1.13 CAPSUGEL (ACQUIRED BY LONZA)
                        TABLE 246 LONZA: BUSINESS OVERVIEW
                        FIGURE 39 LONZA: COMPANY SNAPSHOT (2021)
*Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.
     13.2 OTHER PLAYERS
             13.2.1 OCT GROUP LLC
             13.2.2 COREX LOGISTICS
             13.2.3 ACNOS PHARMA GMBH
             13.2.4 CLINICAL SERVICES INTERNATIONAL
             13.2.5 KLIFO
             13.2.6 CLINIGEN LIMITED
             13.2.7 ANCILLARE, LP
             13.2.8 N-SIDE
             13.2.9 ADALLEN PHARMA
             13.2.10 DURBIN
             13.2.11 RECIPHARM AB
             13.2.12 MOVIANTO

14 APPENDIX (Page No. - 257)
     14.1 DISCUSSION GUIDE
     14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’  SUBSCRIPTION PORTAL
     14.3 CUSTOMIZATION OPTIONS
     14.4 RELATED REPORTS
     14.5 AUTHOR DETAILS